Full-Time
Stryker
10,001+ employees
Develops and manufactures medical devices and equipment
No salary listed
Junior, Mid
Company Historically Provides H1B Sponsorship
Noida, Uttar Pradesh, India
- Diploma or Bachelor's in Mechanical Engineering or similar domain 2-4 years of work experience.
- Prior experience in UDI part marking projects.
- Experience in using UG NX, Creo, SolidWorks, Teamcenter & windchill.
- Understanding of change management process.
- Lead the design and development of solutions for legacy products (Sustenance Engineering).
- Collaborate with cross-functional teams (Quality, Regulatory, Operations) across time zones to execute projects.
- Contribute to value improvement and design optimization activities. Implement drawing and model changes in CAD.
- Coordinate with internal and external manufacturers to decide on the implementation of proposed changes.
- Make decisions and document part marking exemptions. Apply various change management systems.
- Update project status in the project database. Support Engineering Change Requests (ECRs).
- Communicate effectively across different functions, locations, and cultures.
- Follow procedures and instructions to provide lean, robust, and meaningful project documentation. Provide input to the team to implement a large project scope efficiently and smartly.
- Proficiency in CAD tools like UG NX, Creo, or SolidWorks.
- Familiarity with PLM systems such as Teamcenter or Windchill.
- Basic understanding of engineering change management processes.
- Good communication skills and ability to work with cross-functional, global teams.
- Knowledge of medical devices and UDI part marking will be an added advantage.
Stryker develops and manufactures medical devices and equipment aimed at improving patient care and surgical efficiency. Their products include surgical tools, neurotechnology devices, and orthopedic implants, which are sold directly to hospitals and clinics. Stryker stands out from competitors by focusing on high-quality products and a commitment to advancing healthcare solutions. The company's goal is to enhance the overall healthcare experience for both professionals and patients.
Company Size
10,001+
Company Stage
IPO
Headquarters
Kalamazoo, Michigan
Founded
1941
Simplify's Take
What believers are saying
- Growing demand for minimally invasive solutions aligns with Stryker's strategic acquisitions.
- The orthopedic implants market growth benefits Stryker's expanding product line.
- Stryker's acquisition of Inari Medical positions it in a high-growth vascular market.
What critics are saying
- Integration challenges from acquisitions may strain Stryker's resources.
- Rapid tech advancements risk obsolescence of Stryker's current products.
- Regulatory scrutiny on acquisitions could delay Stryker's market entry.
What makes Stryker unique
- Stryker's acquisitions enhance its minimally invasive surgical solutions portfolio.
- Entry into the peripheral vascular segment diversifies Stryker's market presence.
- Stryker's focus on AI integration boosts diagnostic accuracy and operational efficiency.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Medical & prescription plans
Supplemental health benefits
Flexible Spending accounts
Employee Assistance Program
Short-term & long-term disability
Tuition reimbursement
401(k) plan
Employee Stock Purchase Plan
Company News
Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced...
/PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of NICO Corporation, a...
Stryker has announced a definitive agreement to acquire Vertos Medical, a privately held company providing a minimally invasive solution.
Stryker has announced a definitive agreement to acquire care.ai.
Stryker (NYSE:SYK) has completed the acquisition of MOLLI Surgical Inc., a company specializing in wire-free soft tissue localization technology for breast conserving surgery. The MOLLI 2 localization system enhances surgical workflow with its small 3.2 mm marker and real-time feedback. This acquisition strengthens Stryker's breast cancer care portfolio, complementing its existing SPY fluorescence imaging technology. For more information, visit www.stryker.com.